Madan Ajay 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Nov 1, 2021
Insider Transaction Report
Form 4
Madan Ajay
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2021-10-28$0.73/sh+106,383$77,660→ 184,671 total - Exercise/Conversion
Stock Option (right to buy)
2021-10-28−106,383→ 0 totalExercise: $0.73Exp: 2028-03-16→ Common Stock (106,383 underlying)
Footnotes (2)
- [F1]Includes 772 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
- [F2]25% of the shares subject to the option vested on July 17, 2017 and 1/48th of the total remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.